Altimmune Adds Lonza as a Manufacturing Partner for Supply of AdCOVID™ its Single-Dose Intranasal Vaccine Candidate for COVID-19
AdCOVID, a Single-dose Intranasal Vaccine for COVID-19 is Designed to Generate a Broad Immune Response…
Month: November 2020
Santhera to Present at Jefferies Virtual London Healthcare Conference
Pratteln, Switzerland, November 11, 2020 – Santhera Pharmaceuticals (SIX: SANN) announces that Dario Eklund, Chief Executive Officer,…
Bone Therapeutics and its collaborators Cerhum, 3D-Side, mSKIL and IREC awarded €3 million in funding under the framework of BioWin, the health cluster of Wallonia, to develop personalized, tissue engineered bone implants
Gosselies, Belgium, 10 November 2020, 7am CET – BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE),…
Praxis Precision Medicines Provides Regulatory Update On PRAX-114 Program
CAMBRIDGE, Mass., Nov. 09, 2020 (GLOBE NEWSWIRE) — Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a…
Indus Holdings, Inc. Announces New Chief Financial Officer
Board Member Brian Shure will join executive team as Chief Financial OfficerSteve Neil will remain…
Supernus Provides Regulatory Updates for SPN-812 and SPN-830
ROCKVILLE, Md., Nov. 09, 2020 (GLOBE NEWSWIRE) — Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a pharmaceutical…
Indus Holdings, Inc. Reports Record Third Quarter 2020 Results
Company delivers strong results despite being adversely affected by California Wildfires Vertically-integrated California cannabis leader…
Catalyst Pharmaceuticals Announces Third Quarter 2020 Financial Results and Provides Business Update
– Firdapse® Third Quarter Net Revenues of $29.2 Million – Company Ends Third Quarter with…
MacroGenics to Participate in Upcoming Investor Conferences
ROCKVILLE, MD, Nov. 09, 2020 (GLOBE NEWSWIRE) — MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical…
Adamis Pharmaceuticals Announces Third Quarter 2020 Financial Results and Business Update
SAN DIEGO, Nov. 09, 2020 (GLOBE NEWSWIRE) — Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today announced…
Surface Oncology to Present at the Cowen IO Next Summit
CAMBRIDGE, Mass, Nov. 09, 2020 (GLOBE NEWSWIRE) — Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology…
Fortress Biotech Reports Third Quarter 2020 Financial Results and Recent Corporate Highlights
Product revenue for the first nine months of 2020 increased 29% year-over-year to $30.8 million…
TG Therapeutics Provides Business Update and Reports Third Quarter 2020 Financial Results
NEW YORK, Nov. 09, 2020 (GLOBE NEWSWIRE) — TG Therapeutics, Inc. (NASDAQ: TGTX) today announced…
Tonix Pharmaceuticals to Present at 3rd Annual Neuropsychiatric Drug Development Summit
CHATHAM, N.J., Nov. 09, 2020 (GLOBE NEWSWIRE) — Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix…
Immutep’s Phase II TACTI-002 Study Reports Encouraging Data at SITC
Sydney, Australia, Nov. 10, 2020 (GLOBE NEWSWIRE) — ASX/Media Release Overall Response Rates (ORR)…
PDS Biotech Initiates VERSATILE-002 Phase 2 Combination Trial of PDS0101-KEYTRUDA® in Recurrent/Metastatic Head and Neck Cancer in Collaboration with Merck
VERSATILE-002 Trial for First Line Treatment of Recurrent/Metastatic Head and Neck Cancer with Combination PDS0101-KEYTRUDA®…
Tricida Announces Third Quarter 2020 Financial Results
SOUTH SAN FRANCISCO, Calif., Nov. 09, 2020 (GLOBE NEWSWIRE) — Tricida, Inc. (Nasdaq: TCDA), a pharmaceutical…
Marrone Bio Innovations, Inc. Reports Third-Quarter 2020 Financial Results
Expansion in international and seed treatment markets led revenue growth and gross margin improvement DAVIS,…
Shockwave Medical Reports Third Quarter 2020 Financial Results
SANTA CLARA, Calif., Nov. 09, 2020 (GLOBE NEWSWIRE) — Shockwave Medical, Inc. (Nasdaq: SWAV), a…
Altimmune Announces Third Quarter 2020 Financial Results and Provides a Business Update
GAITHERSBURG, Md., Nov. 09, 2020 (GLOBE NEWSWIRE) — Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical…